HPV

Scan to diagnose head and neck cancer
#Cancer research #Head and neck cancer #HPV #Protein targets #Ubiquitin-proteasome

What impact could protein stabilisation have for cancer patients?

The latest episode of the DDW ‘In Conversation With’ series is available to listen to below. This week, Bruno Quinney speaks to Anthony Johnson and Matthew Fyfe from Outrun Therapeutics. Outrun is a biotech specialising in protein stabilisation, an approach being applied to treat HPV+ head and… Read More

#Cancer Research #Featured Podcasts #Podcasts

Nasal spray
#Cancer treatment #Cervical cancer #HPV #Immunology / Virology & Vaccines #Oncology

Scientists create nasal vaccine for treating cervical cancer

Researchers at Chiba University in Japan have developed a new nasal therapeutic vaccine as a non-invasive treatment option for cervical cancer.   Cervical cancer is primarily caused by the human papillomavirus (HPV), but there are no approved therapeutic medicines to treat existing infections or HPV-associated cancers. … Read More

#Cancer Research #Editor's Choice #News

Close up of vaccine syringe
#Cancer vaccine #HPV #Immunology / Virology & Vaccines #Oncology #Phase II trial #Women's health

Therapeutic HPV vaccine could eliminate precancerous cervical lesions

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).  Dr Refika Yigit, principal investigator and Oncological Gynaecologist at University… Read More

#Cancer Research #News

CRISPR gene editing
#CRISPR #CRISPR-Cas9 #Gene editing #HPV #Immunotherapy #iPSC #Oncology

Discovery paves the way to ‘off-the-shelf’ cervical cancer therapy

Researchers from Japan have used CRISPR gene editing to enhance the effectiveness of rejuvenated cytotoxic T lymphocytes (rejTs) for targeted immunotherapy. RejTs constitute a promising approach for treating cervical cancer, though rejection by the host’s immune system is a major hurdle. In a recent… Read More

#Cancer Research #Editor's Choice #News

Teenage boy having vaccination
#AACR 2023 #Cancer research #HPV #Oncology #Vaccines

Awareness of the link between HPV and cancer has declined

Americans have become less aware that the human papillomavirus (HPV) causes cervical cancer in recent years, according to survey data presented at the AACR Annual Meeting 2023. Survey respondents also showed low awareness that HPV can cause anal, oral, and penile cancer. “Over 90%… Read More

#News

#Biologics / Biotechnology #CAR-T #China #CRISPR #Drug discovery #Gene editing #Genetics / genomics #HIV #HPV #Oncology #Pharmacology #T cell activation #The Dose

The Dose: DDW’s drug discovery highlights

DDW highlights the most interesting global news and comments within the drug discovery and development sector this month.   Everyone enjoys a good news story and the drug discovery and development sector is no exception. Seeing tangible results of drug efficacy or therapeutics programmes can take years so it… Read More

#Exclusive Content

#Cancer research #Drug delivery #Drug development #HPV #Immunology / Virology & Vaccines

HPV vaccine proven to dramatically reduce cervical cancer 

After decades of research, the UK implemented a human papillomavirus (HPV) vaccine programme for teenage girls in 2008. Now, for the first time, a study has shown that the UK HPV vaccine programme works and will save lives, according to research funded by Cancer Research UK.  The vaccine was shown to… Read More

#News